8-Oct-2025 5:00 AM CST - Business Wire Oscar Health, Inc. 2025 Third Quarter Earnings Conference Call Oscar Health, Inc. (Oscar or the Company) (NYSE: OSCR), a leading healthcare technology company, will release its third quarter 2025 financial results before the market opens on Thursday, November 6, 2025. Management will review these results in a conference call beginning at 8:00 AM (ET). The call-in number and webcast link are as follows: Live Call: 1.855.761.5600 Conference ID: 7768132 Webcast The call will be archived and available on Oscars investor relation
6-Aug-2025 5:00 AM CST - Business Wire Oscar Health Announces Financial Results for Second Quarter 2025 and Reaffirms Updated 2025 Guidance Oscar Health, Inc. (Oscar or the Company) (NYSE: OSCR) announced today its financial results for the second quarter ended June 30, 2025, and reaffirmed its updated full year 2025 outlook across all metrics as provided in its preliminary financial results press release dated July 22, 2025. We believe the individual market has long-term upside and is the future of healthcare, said Mark Bertolini, CEO of Oscar Health. Oscar is well-positioned to manage through the
22-Jul-2025 5:00 AM CST - Business Wire Oscar Health Announces Preliminary Financial Results for Second Quarter 2025 and Revises 2025 Guidance Oscar Health, Inc. (Oscar or the Company) (NYSE: OSCR), a leading healthcare technology company, announced today certain preliminary financial results for the second quarter ended June 30, 2025 and updates to full year 2025 guidance. The Company expects a loss from operations of approximately $230 million and a net loss of approximately $228 million for the second quarter of 2025. The preannouncement is driven by a review of 2025 Marketplace data (2Q Risk Adjustm
7-May-2025 5:00 AM CST - Business Wire Oscar Health Announces Strong Financial Results for First Quarter 2025 And Reaffirms 2025 Guidance Oscar Health, Inc. (Oscar or the Company) (NYSE: OSCR), a leading healthcare technology company, announced today its financial results for the first quarter ended March 31, 2025. Oscar reported strong financial results in the first quarter, said Mark Bertolini, CEO of Oscar Health. We delivered continued top-line growth and bottom-line performance with significant year-over-year increases in revenue and net income. We continue to expect meaningful margin expans
9-Apr-2025 7:00 AM CST - Business Wire Oscar Health, Inc. 2025 First Quarter Earnings Conference Call Oscar Health, Inc. (Oscar or the Company) (NYSE: OSCR), a leading healthcare technology company, will release its first quarter 2025 financial results before the market opens on Wednesday, May 7, 2025. Management will review these results in a conference call beginning at 8:00 AM (ET). The call-in number and webcast link are as follows: Live Call: 1.855.761.5600 Conference ID: 7768132 Webcast The call will be archived and available on Oscars investor relations we
4-Feb-2025 3:05 PM CST - Business Wire Oscar Health Announces Fourth Quarter and Full Year 2024 Results; Introduces Full Year 2025 Outlook Oscar Health, Inc. (Oscar or the Company) (NYSE: OSCR), a leading healthcare technology company, today announced its financial results for the fourth quarter and full year ended December 31, 2024. Oscar reported positive full year 2024 results, capping the strongest year of financial performance in Company history, said Mark Bertolini, CEO of Oscar Health. We reported both Adjusted EBITDA and net income profitability two significant milestones. Our strong top
9-Jan-2025 7:00 AM CST - Business Wire Oscar Health, Inc. 2024 Fourth Quarter and Full Year Earnings Conference Call Oscar Health, Inc. (Oscar or the Company) (NYSE: OSCR), a leading healthcare technology company, will release its fourth quarter and full year 2024 financial results after the market closes on Tuesday, February 4, 2025. Management will review these results in a conference call beginning at 5:00 PM (ET). The call-in number and webcast link are as follows: Live Call: 1.855.761.5600 Conference ID: 7768132 Webcast The call will be archived and available on Oscars inv
8-Oct-2024 7:00 AM CST - Business Wire Oscar Health, Inc. 2024 Third Quarter Conference Call Oscar Health, Inc. (Oscar or the Company) (NYSE: OSCR), a leading healthcare technology company, will release its third quarter 2024 financial results before the market opens on Thursday, November 7, 2024. Management will review these results in a conference call beginning at 8:00 AM (ET). The call-in number and webcast link are as follows: Live Call: 1.888.596.4244 Conference ID: 7768132 Webcast Link The call will be archived and available on Oscars investor rel
8-Oct-2025 5:00 AM CST - Business Wire Oscar Health, Inc. 2025 Third Quarter Earnings Conference Call Oscar Health, Inc. (Oscar or the Company) (NYSE: OSCR), a leading healthcare technology company, will release its third quarter 2025 financial results before the market opens on Thursday, November 6, 2025. Management will review these results in a conference call beginning at 8:00 AM (ET). The call-in number and webcast link are as follows: Live Call: 1.855.761.5600 Conference ID: 7768132 Webcast The call will be archived and available on Oscars investor relation
6-Aug-2025 5:00 AM CST - Business Wire Oscar Health Announces Financial Results for Second Quarter 2025 and Reaffirms Updated 2025 Guidance Oscar Health, Inc. (Oscar or the Company) (NYSE: OSCR) announced today its financial results for the second quarter ended June 30, 2025, and reaffirmed its updated full year 2025 outlook across all metrics as provided in its preliminary financial results press release dated July 22, 2025. We believe the individual market has long-term upside and is the future of healthcare, said Mark Bertolini, CEO of Oscar Health. Oscar is well-positioned to manage through the
22-Jul-2025 5:00 AM CST - Business Wire Oscar Health Announces Preliminary Financial Results for Second Quarter 2025 and Revises 2025 Guidance Oscar Health, Inc. (Oscar or the Company) (NYSE: OSCR), a leading healthcare technology company, announced today certain preliminary financial results for the second quarter ended June 30, 2025 and updates to full year 2025 guidance. The Company expects a loss from operations of approximately $230 million and a net loss of approximately $228 million for the second quarter of 2025. The preannouncement is driven by a review of 2025 Marketplace data (2Q Risk Adjustm
7-May-2025 5:00 AM CST - Business Wire Oscar Health Announces Strong Financial Results for First Quarter 2025 And Reaffirms 2025 Guidance Oscar Health, Inc. (Oscar or the Company) (NYSE: OSCR), a leading healthcare technology company, announced today its financial results for the first quarter ended March 31, 2025. Oscar reported strong financial results in the first quarter, said Mark Bertolini, CEO of Oscar Health. We delivered continued top-line growth and bottom-line performance with significant year-over-year increases in revenue and net income. We continue to expect meaningful margin expans
9-Apr-2025 7:00 AM CST - Business Wire Oscar Health, Inc. 2025 First Quarter Earnings Conference Call Oscar Health, Inc. (Oscar or the Company) (NYSE: OSCR), a leading healthcare technology company, will release its first quarter 2025 financial results before the market opens on Wednesday, May 7, 2025. Management will review these results in a conference call beginning at 8:00 AM (ET). The call-in number and webcast link are as follows: Live Call: 1.855.761.5600 Conference ID: 7768132 Webcast The call will be archived and available on Oscars investor relations we
4-Feb-2025 3:05 PM CST - Business Wire Oscar Health Announces Fourth Quarter and Full Year 2024 Results; Introduces Full Year 2025 Outlook Oscar Health, Inc. (Oscar or the Company) (NYSE: OSCR), a leading healthcare technology company, today announced its financial results for the fourth quarter and full year ended December 31, 2024. Oscar reported positive full year 2024 results, capping the strongest year of financial performance in Company history, said Mark Bertolini, CEO of Oscar Health. We reported both Adjusted EBITDA and net income profitability two significant milestones. Our strong top
9-Jan-2025 7:00 AM CST - Business Wire Oscar Health, Inc. 2024 Fourth Quarter and Full Year Earnings Conference Call Oscar Health, Inc. (Oscar or the Company) (NYSE: OSCR), a leading healthcare technology company, will release its fourth quarter and full year 2024 financial results after the market closes on Tuesday, February 4, 2025. Management will review these results in a conference call beginning at 5:00 PM (ET). The call-in number and webcast link are as follows: Live Call: 1.855.761.5600 Conference ID: 7768132 Webcast The call will be archived and available on Oscars inv
8-Oct-2024 7:00 AM CST - Business Wire Oscar Health, Inc. 2024 Third Quarter Conference Call Oscar Health, Inc. (Oscar or the Company) (NYSE: OSCR), a leading healthcare technology company, will release its third quarter 2024 financial results before the market opens on Thursday, November 7, 2024. Management will review these results in a conference call beginning at 8:00 AM (ET). The call-in number and webcast link are as follows: Live Call: 1.888.596.4244 Conference ID: 7768132 Webcast Link The call will be archived and available on Oscars investor rel
